Qingdong Guan

机构：Health Sciences Centre, CancerCare Manitoba, Research Institute in Oncology and Hematology, University of Manitoba · ORCID：0000-0003-1972-487X

发表论文 62 篇 · 总被引 2427 次 · h-index 21

代表论文

• A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease (2019 · Journal of Immunology Research · 被引 1076)
• Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial (2021 · The Lancet Neurology · 被引 113)
• Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis (2020 · Mediators of Inflammation · 被引 88)
• Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells (2018 · Cytotherapy · 被引 77)
• A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies (2018 · JCI Insight · 被引 44)
• Interferon γ induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells (2017 · Clinical Proteomics · 被引 36)